AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10567289 — intervention group
Group type: EXPERIMENTAL
Intervention: NYHA class severity
Number of subjects: 900
Study 9590840 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% miconazole suspension
Number of subjects: 73
Study 9590840 — intervention group
Group type: EXPERIMENTAL
Intervention: Imidazole mixed oil (econazole and miconazole in castor oil)
Number of subjects: 73
Study 9590840 — intervention group
Group type: EXPERIMENTAL
Intervention: Dusting mixed imidazole powder onto focal corneal lesions
Number of subjects: 73
Study 9590840 — intervention group
Group type: COMPARATOR
Intervention: Focal corneal lesion resection combined with dusting mixed imidazole powder
Number of subjects: 73
Study 1747568 — intervention group
Group type: EXPERIMENTAL
Intervention: Nandrolone decanoate (ND; 50 mg IM every three weeks)
Number of subjects: 35
Study 1747568 — intervention group
Group type: COMPARATOR
Intervention: Control group 1 (CST therapy for less years)
Number of subjects: 35
Study 1747568 — intervention group
Group type: COMPARATOR
Intervention: Control group 2 (pair-matched control)
Number of subjects: 35
Study 1747568 — intervention group
Group type: EXPERIMENTAL
Intervention: Nandrolone decanoate (ND)
Number of subjects: 35
Study 31684914 — intervention group
Group type: EXPERIMENTAL
Intervention: Dog acquisition group (n=17)
Number of subjects: 71
Study 31684914 — intervention group
Group type: COMPARATOR
Intervention: Lagged control group (n=29)
Number of subjects: 71
Study 31684914 — intervention group
Group type: COMPARATOR
Intervention: Community control group (n=25)
Number of subjects: 71
Study 28089425 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal Tube (LT)
Number of subjects: 52
Study 28089425 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway Supreme
Number of subjects: 52
Study 28089425 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway I‐Gel
Number of subjects: 52
Study 28089425 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway Unique
Number of subjects: 52
Study 28089425 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway Aura‐once
Number of subjects: 52
Study 26041559 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic surgery
Number of subjects: 244
Study 26041559 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic surgery
Number of subjects: 244
Study 24063835 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple antiplatelet therapy (aspirin, clopidogrel, and cilostazol); n = 700
Number of subjects: 1399
Study 24063835 — intervention group
Group type: COMPARATOR
Intervention: Dual antiplatelet therapy (aspirin and clopidogrel); n = 699
Number of subjects: 1399
Study 20837822 — intervention group
Group type: EXPERIMENTAL
Intervention: FDG-PET imaging during resting state
Number of subjects: 29
Study 20837822 — intervention group
Group type: EXPERIMENTAL
Intervention: FDG-PET imaging during memory encoding task
Number of subjects: 29
Study 20837822 — intervention group
Group type: EXPERIMENTAL
Intervention: HOMA-IR correlation with CMRglu values
Number of subjects: 29
Study 19691668 — intervention group
Group type: EXPERIMENTAL
Intervention: Viusid (three sachets daily) with hypocaloric diet and aerobic exercise
Number of subjects: 60
Study 19691668 — intervention group
Group type: COMPARATOR
Intervention: Control group (hypocaloric diet and exercise)
Number of subjects: 60
Study 17537781 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonorgestrel (1.5 mg)
Number of subjects: 15
Study 14998842 — intervention group
Group type: EXPERIMENTAL
Intervention: gemcitabine plus irinotecan
Number of subjects: 80
Study 14998842 — intervention group
Group type: EXPERIMENTAL
Intervention: gemcitabine plus docetaxel
Number of subjects: 80
Study 11452247 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus
Number of subjects: 1336
Study 11452247 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine
Number of subjects: 1336
Study 10182433 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-week broad-spectrum intervention for bereaved parents
Number of subjects: 0
Study 8018787 — intervention group
Group type: EXPERIMENTAL
Intervention: Illumination exposure
Number of subjects: 106
Study 8018787 — intervention group
Group type: EXPERIMENTAL
Intervention: CES-D depression score
Number of subjects: 106
Study 2916469 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioactivator only
Number of subjects: 76
Study 2916469 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioactivator plus headgear
Number of subjects: 76
Study 2916469 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated subjects)
Number of subjects: 76
Study 821675 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 5
Study 29430998 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidimensional memory program
Number of subjects: 67
Study 29430998 — intervention group
Group type: COMPARATOR
Intervention: No-contact control group
Number of subjects: 67
Study 28138980 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-daily dosing of canagliflozin
Number of subjects: 1347
Study 28138980 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-daily dosing of canagliflozin
Number of subjects: 1347
Study 28138980 — intervention group
Group type: COMPARATOR
Intervention: Canagliflozin (both dosing regimens)
Number of subjects: 1347
Study 25212474 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention with face-to-face teaching
Number of subjects: 162
Study 25212474 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention without face-to-face teaching
Number of subjects: 162
Study 25212474 — intervention group
Group type: COMPARATOR
Intervention: Routine care (Control group)
Number of subjects: 162
Study 23351269 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention hospitals (based on maternal death review)
Number of subjects: 658
Study 23351269 — intervention group
Group type: COMPARATOR
Intervention: Control hospitals
Number of subjects: 658
Study 23351269 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention hospitals (after adjustment)
Number of subjects: 658
Study 21736448 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous (i.v.) administration of erythropoietin (EPO) for 4 months
Number of subjects: 145
Study 21736448 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous (s.c.) administration of erythropoietin (EPO) for 4 months
Number of subjects: 145
Study 18443671 — intervention group
Group type: EXPERIMENTAL
Intervention: CR tramadol (150 mg daily, titrated to a maximum of 400 mg once daily)
Number of subjects: 100
Study 18443671 — intervention group
Group type: EXPERIMENTAL
Intervention: CR tramadol
Number of subjects: 100
Study 16869001 — intervention group
Group type: EXPERIMENTAL
Intervention: ABN912
Number of subjects: 45
Study 16869001 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 12493646 — intervention group
Group type: EXPERIMENTAL
Intervention: High tidal volume mechanical ventilation
Number of subjects: 0
Study 12493646 — intervention group
Group type: COMPARATOR
Intervention: Low tidal volume mechanical ventilation
Number of subjects: 0
Study 10638884 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal bilevel training (45 minutes daily, 5 days a week for 6 weeks, working 2.03+/‐0.4 kJ/kg per session)
Number of subjects: 13
Study 10638884 — intervention group
Group type: COMPARATOR
Intervention: O2 cart pushers (45 minutes daily, 5 days a week for 6 weeks, working 1.44+/‐.35 kJ/kg per session)
Number of subjects: 13
Study 9338536 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic inhaled steroids
Number of subjects: 24
Study 1524961 — intervention group
Group type: EXPERIMENTAL
Intervention: Plain prednisolone tablets (30 mg)
Number of subjects: 16
Study 1524961 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteric-coated prednisolone tablets (30 mg)
Number of subjects: 16
Study 1524961 — intervention group
Group type: EXPERIMENTAL
Intervention: Plain and enteric-coated prednisolone tablets (30 mg)
Number of subjects: 16
Study 3156329 — intervention group
Group type: EXPERIMENTAL
Intervention: Bolus intravenous injection of fibronectin (1 mg/kg)
Number of subjects: 10
Study 3156329 — intervention group
Group type: EXPERIMENTAL
Intervention: Bolus injection of one-half of the dose followed by continuous infusion of the remaining half-dose over a 6-hour period (group B + P)
Number of subjects: 10
Study 29485234 — intervention group
Group type: EXPERIMENTAL
Intervention: Ionization
Number of subjects: 24
Study 29485234 — intervention group
Group type: EXPERIMENTAL
Intervention: Wood shavings and haylage
Number of subjects: 24
Study 29485234 — intervention group
Group type: COMPARATOR
Intervention: Straw and dry hay
Number of subjects: 24
Study 27159166 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular (IM) immunization with CN54 gp140 at 20 or 100 μg co-administered with Glucopyranosyl Lipid Adjuvant (GLA)
Number of subjects: 0
Study 27159166 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal (IN) immunization with CN54 gp140 and 0.5% chitosan
Number of subjects: 0
Study 27159166 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravaginal (IVAG) immunization with CN54 gp140 in an aqueous gel
Number of subjects: 0
Study 27159166 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular (IM) boosting after IN priming
Number of subjects: 0
Study 27159166 — intervention group
Group type: EXPERIMENTAL
Intervention: IM groups
Number of subjects: 0
Study 24107072 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK2336805 + PEG/RIBA
Number of subjects: 16
Study 24107072 — intervention group
Group type: COMPARATOR
Intervention: Placebo + PEG/RIBA
Number of subjects: 16
Study 24107072 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK2336805 (monotherapy)
Number of subjects: 16
Study 24107072 — intervention group
Group type: COMPARATOR
Intervention: Placebo (monotherapy)
Number of subjects: 16
Study 22784346 — intervention group
Group type: EXPERIMENTAL
Intervention: Sahaja yoga meditation
Number of subjects: 67
Study 22784346 — intervention group
Group type: COMPARATOR
Intervention: Control group (Mahatma Gandhi Mission Hospital treatment)
Number of subjects: 67
Study 20833796 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose of alcohol (target BAC = .10%)
Number of subjects: 0
Study 20833796 — intervention group
Group type: COMPARATOR
Intervention: No alcohol
Number of subjects: 0
Study 18231713 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium valproate (VPA)
Number of subjects: 70
Study 18231713 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 16164447 — intervention group
Group type: EXPERIMENTAL
Intervention: salbutamol (5 mg/mL)
Number of subjects: 9
Study 16164447 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 9
Study 12753877 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol/acetaminophen combination tablets (37.5 mg tramadol/325 mg acetaminophen)
Number of subjects: 315
Study 11103223 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat lunch
Number of subjects: 15
Study 11103223 — intervention group
Group type: COMPARATOR
Intervention: High-carbohydrate lunch
Number of subjects: 15
Study 11103223 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat snack
Number of subjects: 15
Study 11103223 — intervention group
Group type: COMPARATOR
Intervention: High-carbohydrate snack
Number of subjects: 15
Study 11103223 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall high-fat foods
Number of subjects: 15
Study 11103223 — intervention group
Group type: COMPARATOR
Intervention: Overall high-carbohydrate foods
Number of subjects: 15
Study 8972812 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous arch wire technique (CAW)
Number of subjects: 50
Study 8972812 — intervention group
Group type: EXPERIMENTAL
Intervention: Segmented arch technique (Burstone)
Number of subjects: 50
Study 1480305 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone propionate 2%
Number of subjects: 40
Study 1480305 — intervention group
Group type: COMPARATOR
Intervention: Clobetasol dipropionate 0.05%
Number of subjects: 40
Study 3001925 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fibre diet
Number of subjects: 95
Study 3001925 — intervention group
Group type: COMPARATOR
Intervention: Unrestricted diet
Number of subjects: 95
Study 3001925 — intervention group
Group type: EXPERIMENTAL
Intervention: Three end-expiratory breath hydrogen sampling methods
Number of subjects: 95
Study 30658677 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 29202850 — intervention group
Group type: EXPERIMENTAL
Intervention: Small Changes (reduce calorie intake by 100 kcals/day & add 2000 steps/day)
Number of subjects: 599
Study 29202850 — intervention group
Group type: EXPERIMENTAL
Intervention: Large Changes (lose 2.3-4.5 kg initially & increase PA to ≥250 min/wk)
Number of subjects: 599
Study 29202850 — intervention group
Group type: COMPARATOR
Intervention: Self-guided (control condition)
Number of subjects: 599
Study 29202850 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups combined
Number of subjects: 599
Study 29202850 — intervention group
Group type: EXPERIMENTAL
Intervention: ≥250 min/wk. of MVPA
Number of subjects: 599
Study 26057780 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixture of pure platelet concentrate and deproteinized bovine bone mineral (test group)
Number of subjects: 6
Study 26057780 — intervention group
Group type: COMPARATOR
Intervention: Deproteinized bovine bone (control group)
Number of subjects: 6
Study 23441841 — intervention group
Group type: EXPERIMENTAL
Intervention: Berberine 500 mg twice a day for 3 months
Number of subjects: 144
Study 23441841 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 144
Study 23441841 — intervention group
Group type: EXPERIMENTAL
Intervention: Berberine after washout period
Number of subjects: 144
Study 21517964 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV7 vaccination
Number of subjects: 96
Study 19375278 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast baths with exercise
Number of subjects: 114
Study 19375278 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast baths without exercise
Number of subjects: 114
Study 19375278 — intervention group
Group type: COMPARATOR
Intervention: Exercise-only control treatment
Number of subjects: 114
Study 16931635 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-nucleotide polymorphism +79 in African Americans
Number of subjects: 669
Study 16931635 — intervention group
Group type: EXPERIMENTAL
Intervention: Haplotype association in African Americans
Number of subjects: 669
Study 16931635 — intervention group
Group type: EXPERIMENTAL
Intervention: Poly-C repeat (+1269) in ADRβ2
Number of subjects: 669
Study 15298636 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 80 mg/day
Number of subjects: 119
Study 15298636 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119
Study 11495220 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat, high-fiber, high-fruit/vegetable diet (20% of energy from fat, 18 g/1,000 kcal/day fiber, 3.5 servings/1,000 kcal/day fruit/vegetable)
Number of subjects: 394
Study 11495220 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat, high-fiber, high-fruit/vegetable diet
Number of subjects: 394
Study 11495220 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard diet)
Number of subjects: 394
Study 10101924 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with newly diagnosed diabetes type 1 who were fed mother's milk (n=19)
Number of subjects: 142
Study 10101924 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with newly diagnosed diabetes type 1 who were fed artificially (n=26)
Number of subjects: 142
Study 10101924 — intervention group
Group type: COMPARATOR
Intervention: Healthy children (n=65)
Number of subjects: 142
Study 7812890 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedocromil sodium 2% eye drops, administered twice daily for 4 weeks
Number of subjects: 149
Study 7812890 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149
Study 3235806 — intervention group
Group type: EXPERIMENTAL
Intervention: Sterile technique for preparation of the skin over the vascular access site
Number of subjects: 71
Study 3235806 — intervention group
Group type: COMPARATOR
Intervention: Clean technique for preparation of the skin over the vascular access site
Number of subjects: 71
Study 3235806 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall infection rate
Number of subjects: 71
Study 3235806 — intervention group
Group type: EXPERIMENTAL
Intervention: Vascular access-site infection rate
Number of subjects: 71
Study 3235806 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacteremia rate
Number of subjects: 71
Study 3235806 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk factors for infections
Number of subjects: 71
Study 31425454 — intervention group
Group type: EXPERIMENTAL
Intervention: Nordic hamstrings exercise (NHE)
Number of subjects: 25
Study 31425454 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric leg curl (ELC)
Number of subjects: 25
Study 31425454 — intervention group
Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 25
Study 31406294 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailed letter intervention
Number of subjects: 228000
Study 31406294 — intervention group
Group type: COMPARATOR
Intervention: No letter (control)
Number of subjects: 228000
Study 31406294 — intervention group
Group type: EXPERIMENTAL
Intervention: Different versions of letters with behavioural science techniques
Number of subjects: 228000
Study 28604015 — intervention group
Group type: EXPERIMENTAL
Intervention: HOPES‐I intervention (1 session per week for 9-12 months)
Number of subjects: 47
Study 26206174 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventions targeting perceived barriers to vegetable intake among boys.
Number of subjects: 424
Study 26206174 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher levels of eating vegetables together with family, previous vegetable intake, and lower perceived barriers.
Number of subjects: 424
Study 26206174 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up measures in 2010.
Number of subjects: 424
Study 26206174 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower level of parental demand for children to eat vegetables.
Number of subjects: 424
Study 26206174 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender differences in predictors of liking vegetables.
Number of subjects: 424
Study 23121256 — intervention group
Group type: EXPERIMENTAL
Intervention: 30% salicylic acid peels
Number of subjects: 13
Study 23121256 — intervention group
Group type: COMPARATOR
Intervention: Jessner's solution peels
Number of subjects: 13
Study 21793631 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT)
Number of subjects: 43
Study 21793631 — intervention group
Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 43
Study 19114895 — intervention group
Group type: EXPERIMENTAL
Intervention: Alkaline phosphatase (AP) treatment
Number of subjects: 36
Study 19114895 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 16518530 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg atorvastatin
Number of subjects: 132
Study 16518530 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg simvastatin
Number of subjects: 132
Study 16518530 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132
Study 12774876 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-bedding
Number of subjects: 37
Study 12774876 — intervention group
Group type: COMPARATOR
Intervention: Control (Single-bedding)
Number of subjects: 37
Study 10699055 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised genetic assessment, genetic counselling, and gene testing (where appropriate) added to typical advice and surveillance from a hospital breast clinic.
Number of subjects: 0
Study 10699055 — intervention group
Group type: COMPARATOR
Intervention: Typical advice and surveillance from a hospital breast clinic.
Number of subjects: 0
Study 9573831 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental laser plus scaling and root planing
Number of subjects: 10
Study 9573831 — intervention group
Group type: COMPARATOR
Intervention: Scaling and root planing alone
Number of subjects: 10
Study 9573831 — intervention group
Group type: COMPARATOR
Intervention: Control only
Number of subjects: 10
Study 8400973 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol 50‐100 mg twice daily
Number of subjects: 42
Study 8400973 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine 2.5‐5.0 mg twice daily
Number of subjects: 42
Study 8400973 — intervention group
Group type: COMPARATOR
Intervention: Calcium entry blockers
Number of subjects: 42
Study 8400973 — intervention group
Group type: COMPARATOR
Intervention: Beta blockers
Number of subjects: 42
Study 3037934 — intervention group
Group type: EXPERIMENTAL
Intervention: Halothane anesthesia
Number of subjects: 30
Study 3037934 — intervention group
Group type: EXPERIMENTAL
Intervention: Enflurane anesthesia
Number of subjects: 30
Study 3037934 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane anesthesia
Number of subjects: 30
Study 3037934 — intervention group
Group type: COMPARATOR
Intervention: Halothane, Enflurane, Isoflurane
Number of subjects: 30
Study 29094444 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (MTF) 1700 mg/day
Number of subjects: 141
Study 29094444 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 141
Study 26847305 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided steroid injection into scalene muscles
Number of subjects: 20
Study 26847305 — intervention group
Group type: COMPARATOR
Intervention: Stretching exercise only
Number of subjects: 20
Study 24802775 — intervention group
Group type: EXPERIMENTAL
Intervention: Avatrombopag 2.5 mg
Number of subjects: 64
Study 24802775 — intervention group
Group type: EXPERIMENTAL
Intervention: Avatrombopag 5 mg
Number of subjects: 64
Study 24802775 — intervention group
Group type: EXPERIMENTAL
Intervention: Avatrombopag 10 mg
Number of subjects: 64
Study 24802775 — intervention group
Group type: EXPERIMENTAL
Intervention: Avatrombopag 20 mg
Number of subjects: 64
Study 24802775 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 24802775 — intervention group
Group type: EXPERIMENTAL
Intervention: Avatrombopag (all doses)
Number of subjects: 64
Study 24802775 — intervention group
Group type: EXPERIMENTAL
Intervention: Avatrombopag
Number of subjects: 64
Study 22508732 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural steroids
Number of subjects: 84